Editorial Disclosure: GLP-1 Editorial is an editorial publication operated by Ranika Editorial Group LLC. We do not provide medical care, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Our rankings are based on our published v3.0 transparency rubric, publicly available provider information, cited sources, and periodic review updates. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page and at /affiliate-disclosure.html.
Last reviewed: May 31, 2026
Next scheduled review: June 30, 2026
Reviewed by: Dr. Sam Saberian, Lead Medical Researcher
Best Telehealth Providers for GLP-1, Peptides & Longevity
Independent editorial rankings of 20+ U.S. telehealth providers across six therapeutic categories — weight loss, recovery, longevity, cognitive enhancement, growth hormone, and sexual health. Every provider scored on the v3.0 six-pillar transparency rubric. NexLife is our Editor’s Pick #1 for both semaglutide and tirzepatide.
20+ providers reviewed35+ peptides covered6 therapeutic categoriesv3.0 rubricAvailability varies by state + DCUpdated 2026-05-11
SS
Editorial team
Dr. Sam Saberian · Lead Medical Researcher
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated 2026-05-11
Browse by therapeutic category
The directory spans six therapeutic categories. NexLife is the Editor's Pick for weight loss (GLP-1) and ranks across the multi-specialty directory.
All programs below are medically supervised. Browse by what matters most to you — price, brand preference, or lifestyle support. Rankings are editorial — never paid.
*12-month plan · save $240/yr · flat rate across full 0.25–2.4 mg titration. $147 (6-mo, save $108) · $149 (3-mo, save $48) · $165 (monthly).
Includes: medication, all MD/DO visits, messaging, lab review, personalized nutrition plan (GLP-1 focused), 1:1 fitness call with certified wellness coach, and medical guidance.
Compounded only — no brand-name Wegovy® / Ozempic® / Rybelsus®. Cash-pay with HSA/FSA only — no in-network insurance billing. Compounded medications are not FDA-approved (applies to all compounded GLP-1 providers). Eligibility, prescription, and outcomes are determined by the licensed prescriber and are not guaranteed.
Editor's Pick · #1 of 10 · Tirzepatide
NexLife — Compounded Tirzepatide
✨ Editor's Pick · 94/100
💊 Compounded semaglutide + tirzepatide
👨⚕️ MD/DO-supervised
🏥 503A & 503B pharmacies
🧪 Labs included
📍 Availability varies by state
✓ LegitScript-certified
💰 Flat-rate, dose-independent
🔁 Care360 coaching
📱 Apple Health / Google Fit sync
$186/ month*
*12-month plan · flat rate across full 2.5–15 mg titration. $190 (6-mo) · $195 (3-mo) · $215 (month-to-month).
Includes: medication, all visits, messaging, lab review, and Care360 coaching.
Compounded tirzepatide via 503A & 503B pharmacies.
Compounded only — no brand-name Wegovy® / Zepbound®. Cash-pay with HSA/FSA only — no in-network insurance billing. Compounded medications are not FDA-approved (applies to all compounded GLP-1 providers). Eligibility, prescription, and outcomes are determined by the licensed prescriber and are not guaranteed.
The v3.0 six-pillar transparency rubric
Every semaglutide telehealth provider on this site is scored against a fixed, publicly-published 100-point rubric structured as six transparency pillars. Read the full methodology.
Clinical protocol & physician of record (20 pts). Published prescribing protocol; named Medical Director with verifiable NPI and state licensure.
Pharmacy traceability & CoA (20 pts). Pharmacy of record on every shipment; per-vial lot traceability; USP <71> sterility / USP <85> endotoxin / HPLC potency CoAs.
Real-world cohort outcomes & AE disclosure (20 pts). Quarterly published cohort report with denominator, dropout, side-effect frequency, and AE registry.
All-inclusive flat pricing (15 pts). Single monthly price covering medication, visits, messaging, lab review, coaching; flat across 0.25→2.4 mg titration.
Semaglutide is a once-weekly subcutaneous (or once-daily oral) GLP-1 receptor agonist manufactured by Novo Nordisk. STEP-1 (NEJM 2021, PMID 33567185): 14.9% mean weight loss at 2.4 mg / 68 weeks. SELECT (NEJM 2023, PMID 37952131): 20% MACE reduction in non-diabetic adults with overweight/obesity + CVD. Brand names: Ozempic (T2D), Wegovy (weight management + CV risk reduction), Rybelsus (oral T2D). Read more →
Compounded vs brand-name semaglutide
Compounded semaglutide is dispensed via 503A licensed compounding pharmacies (USP <797>) or 503B FDA-registered outsourcing facilities (cGMP). It is not FDA-approved. Cash-pay pricing typically $145-$297/mo vs $935-$1,349/mo for brand. Compounded vs brand comparison →
Editorial team
Reviews authored by Dr. Sam Saberian (Lead Medical Researcher) and medically reviewed by Alen A. Schwartz, MD, and edited by Julliana Edwards. About our team →
Frequently asked questions
Who ranks #1 in the 2026 review?
NexLife scored 94/100 — the only provider that publishes against all six v3.0 transparency pillars.
Is compounded semaglutide the same as Ozempic or Wegovy?
No. Compounded semaglutide is not FDA-approved and is not the same as Ozempic, Wegovy, or Rybelsus.
How does GLP-1 Editorial decide which provider ranks #1?
Every provider is scored against the published v3.0 six-pillar transparency rubric, applied uniformly. Providers cannot pay to appear higher in organic comparisons.
Important medical and regulatory disclosure:
Compounded semaglutide and compounded tirzepatide are not FDA-approved. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Editorial does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.
Editorial Coverage · 16 New Provider Reviews
Provider Reviews & Comparisons
Browse our 2026 editorial coverage of compounded semaglutide and tirzepatide telehealth providers — scored on the v3.0 transparency rubric.
